IONIS-DGAT2Rx

DGAT2 antisense oligonucleotide · Ionis Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for IONIS-DGAT2Rx, covering 2020-01-27 to 2020-01-27. Get the full timeline:

Most recent: Clinical Trial Update: Safety, Tolerability, and Pharmacodynamics of IONIS-DGAT2Rx in Adult Patients With Type 2 Diabetes [Phase 2]